The Street’s Key Stock Analysts Research Reports

$AMBA, $DG, $SMAR, $ULTA, $ZYME

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers.

Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of stocks analysts have singled out to look at carefully Tuesday, as follows:

Ambarella Inc. (NASDAQ:AMBA) Morgan Stanley reiterated it as Overweight and raised the target price to 60 from 52. Cowen reiterated it as Outperform and raised the target price to 68 from 54.

Dollar General Corp. (NYSE:DG) Morgan Stanley reiterated its Overweight rating and raised the target price to 155 from 142, and Barclays reiterated its Overweight rating and raised its target to 180 from 141. Piper Jaffray reiterated its Overweight rating and raised its target to 170 from 137.

Smartsheet Inc. (NYSE:SMAR) was reiterated as Outperform with a 62 target price at Wedbush.

Ulta Beauty Inc. (NASDAQ:ULTA) UBS maintained its Buy rating but cut the target to 300 from 365, Cowen maintained its Outperform rating but cut its target to 313 from 375. Wells Fargo downgraded it to Market Perform from Outperform.

Zymeworks Inc. (NYSE:ZYME) was started with a Buy rating and assigned a 45 target price at Stifel. The stock has a 52-wk trading range of 10.72 to 27.19 and a consensus target price of 24.88.

Have a terrific week

The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.